Have a personal or library account? Click to login
Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review Cover

Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review

Tremor and Other Hyperkinetic Movements
Volume 13 (2023): Issue 1
By: Yasaman Safarpour,  Nosratola D. Vaziri and  Bahman Jabbari  
Open Access
|Mar 2023

References

  1. 1Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017 Mar 25; 389(10075): 1238–1252. Epub 2016 Nov 23. PMID: 27887750. DOI: 10.1016/S0140-6736(16)32064-5
    Back to article
  2. 2Ammirati AL. Chronic Kidney Disease. Rev Assoc Med Bras (1992). 2020 Jan 13; 66(Suppl 1): s03–s09. PMID: 31939529. DOI: 10.1590/1806-9282.66.s1.3
    Back to article
  3. 3Roumelioti ME, Buysse DJ, Sanders MH, Strollo P, Newman AB, Unruh ML. Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol. 2011 May; 6(5): 986–94. Epub 2011 Mar 24. PMID: 21441128; PMCID: PMC3087794. DOI: 10.2215/CJN.05720710
    Back to article
  4. 4Novak M, Winkelman JW, Unruh M. Restless Legs Syndrome in Patients with Chronic Kidney Disease. Semin Nephrol. 2015 Jul; 35(4): 347–58. PMID: 26355253. DOI: 10.1016/j.semnephrol.2015.06.006
    Back to article
  5. 5Lin Z, Zhao C, Luo Q, Xia X, Yu X, Huang F. Prevalence of restless legs syndrome in chronic kidney disease: a systematic review and meta-analysis of observational studies. Ren Fail. 2016 Oct; 38(9): 1335–1346. Epub 2016 Oct 20. PMID: 27765002. DOI: 10.1080/0886022X.2016.1227564
    Back to article
  6. 6Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003 Mar; 4(2): 101–19. PMID: 14592341. DOI: 10.1016/S1389-9457(03)00010-8
    Back to article
  7. 7Venkateshiah SB, Ioachimescu OC. Restless legs syndrome. Crit Care Clin. 2015 Jul; 31(3): 459–72. Epub 2015 May 1. PMID: 26118915. DOI: 10.1016/j.ccc.2015.03.003
    Back to article
  8. 8Vlasie A, Trifu SC, Lupuleac C, Kohn B, Cristea MB. Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review). Exp Ther Med. 2022 Feb; 23(2): 185. DOI: 10.3892/etm.2021.11108. Epub 2021 Dec 30. PMID: 35069866; PMCID: PMC8764906
    Back to article
  9. 9Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless Legs Syndrome: Contemporary Diagnosis and Treatment. Neurotherapeutics. 2021 Jan; 18(1): 140–155. Epub 2021 Apr 20. PMID: 33880737; PMCID: PMC8116476. DOI: 10.1007/s13311-021-01019-4
    Back to article
  10. 10Anguelova GV, Vlak MHM, Kurvers AGY, Rijsman RM. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome. Sleep Med Clin. 2020 Jun; 15(2): 277–288. PMID: 32386701. DOI: 10.1016/j.jsmc.2020.02.013
    Back to article
  11. 11Walters AS, Moussouttas M, Siddiqui F, Silveira DC, Fuentes K, Wang L, Berger K. Prevalence of stroke in Restless Legs Syndrome: Initial Results Point to the Need for More Sophisticated Studies. Open Neurol J. 2010 Jun 15; 4: 73–7. PMID: 20721325; PMCID: PMC2923374. DOI: 10.2174/1874205X01004010073
    Back to article
  12. 12Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. International Restless Legs Syndrome Study Group. Sleep Med. 2014 Aug; 15(8): 860–73. DOI: 10.1016/j.sleep.2014.03.025
    Back to article
  13. 13Zadeh Saraji N, Hami M, Boostani R, Mojahedi MJ. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. J Renal Inj Prev. 2016 Dec 25; 6(2): 137–141. PMID: 28497091; PMCID: PMC5423282. DOI: 10.15171/jrip.2017.27
    Back to article
  14. 14Hasheminasab Zaware R, Mahmoodi Meymand MH, Rezaeian M, Mohammadi Kamalabadi N, Mostafavi SA, Abdolkarimi Dawarani MA, Jome Yazdian R, Bidaki R. Insomnia and Restless Leg Syndrome in Patients Undergoing Chronic Hemodialysis in Rafsanjan Ali Ibn Abitaleb Hospital. Nephrourol Mon. 2016 Jan 9; 8(1): e29527. PMID: 26981494; PMCID: PMC4780113. DOI: 10.5812/numonthly.29527
    Back to article
  15. 15Naini AE, Amra B, Mahmoodnia L, Taheri S. Sleep apnea syndrome and restless legs syndrome in kidney transplant recipients. Adv Biomed Res. 2015 Sep 28; 4: 206. PMID: 26605235; PMCID: PMC4627182. DOI: 10.4103/2277-9175.166142
    Back to article
  16. 16Al-Jahdali HH, Al-Qadhi WA, Khogeer HA, Al-Hejaili FF, Al-Ghamdi SM, Al Sayyari AA. Restless legs syndrome in patients on dialysis. Saudi J Kidney Dis Transpl. 2009 May; 20(3): 378–85. PMID: 19414938.
    Back to article
  17. 17Hui DS, Wong TY, Ko FW, Li TS, Choy DK, Wong KK, Szeto CC, Lui SF, Li PK. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000 Oct; 36(4): 783–8. PMID: 11007681. DOI: 10.1053/ajkd.2000.17664
    Back to article
  18. 18Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995 Nov; 26(5): 751–6. PMID: 7485127. DOI: 10.1016/0272-6386(95)90438-7
    Back to article
  19. 19Haider I, Anees M, Shahid SA. Restless legs syndrome in end stage renal disease patients on haemodialysis. Pak J Med Sci. 2014 Nov–Dec; 30(6): 1209–12. PMID: 25674109; PMCID: PMC4320701. DOI: 10.12669/pjms.306.5691
    Back to article
  20. 20Markou N, Kanakaki M, Myrianthefs P, Hadjiyanakos D, Vlassopoulos D, Damianos A, Siamopoulos K, Vasiliou M, Konstantopoulos S. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung. 2006 Jan–Feb; 184(1): 43–9. PMID: 16598651. DOI: 10.1007/s00408-005-2563-2
    Back to article
  21. 21Bhowmik D, Bhatia M, Tiwari S, Mahajan S, Gupta S, Agarwal SK, Dash SC. Low prevalence of restless legs syndrome in patients with advanced chronic renal failure in the Indian population: a case controlled study. Ren Fail. 2004 Jan; 26(1): 69–72. PMID: 15083925. DOI: 10.1081/JDI-120028557
    Back to article
  22. 22Capelli I, Pizza F, Ruggeri M, Gasperoni L, Carretta E, Donati G, Cianciolo G, Plazzi G, La Manna G. Time evolution of restless legs syndrome in haemodialysis patients. Clin Kidney J. 2019 Dec 16; 14(1): 341–347. PMID: 33564437; PMCID: PMC7857816. DOI: 10.1093/ckj/sfz148
    Back to article
  23. 23Chrastina M, Martinková J, Minar M, Zilinska Z, Valkovic P, Breza J. Impact of kidney transplantation on restless legs syndrome. Bratisl Lek Listy. 2015; 116(7): 404–7. PMID: 26286241. DOI: 10.4149/BLL_2015_077
    Back to article
  24. 24Szentkiralyi A, Molnar MZ, Czira ME, Deak G, Lindner AV, Szeifert L, Torzsa P, Vamos EP, Zoller R, Mucsi I, Novak M. Association between restless legs syndrome and depression in patients with chronic kidney disease. J Psychosom Res. 2009 Aug; 67(2): 173–80. PMID: 19616146. DOI: 10.1016/j.jpsychores.2009.05.004
    Back to article
  25. 25Azar SA, Hatefi R, Talebi M. Evaluation of effect of renal transplantation in treatment of restless legs syndrome. Transplant Proc. 2007 May; 39(4): 1132–3. PMID: 17524912. DOI: 10.1016/j.transproceed.2007.03.097
    Back to article
  26. 26Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord. 2002 Sep; 17(5): 1072–6. PMID: 12360562. DOI: 10.1002/mds.10231
    Back to article
  27. 27Stefanidis I, Vainas A, Giannaki CD, Dardiotis E, Spanoulis A, Sounidaki M, Eleftheriadis T, Liakopoulos V, Karatzaferi C, Sakkas GK, Zintzaras E, Hadjigeorgiou GM. Restless legs syndrome does not affect 3-year mortality in hemodialysis patients. Sleep Med. 2015 Sep; 16(9): 1131–8. Epub 2015 Jun 19. PMID: 26298790. DOI: 10.1016/j.sleep.2015.04.023
    Back to article
  28. 28Lin CH, Sy HN, Chang HW, Liou HH, Lin CY, Wu VC, Wu SL, Chang CC, Chiu PF, Li WY, Lin SY, Wu KD, Chen YM, Wu RM. Restless legs syndrome is associated with cardio/cerebrovascular events and mortality in end-stage renal disease. Eur J Neurol. 2015 Jan; 22(1): 142–9. Epub 2014 Aug 21. PMID: 25142748. DOI: 10.1111/ene.12545
    Back to article
  29. 29La Manna G, Pizza F, Persici E, Baraldi O, Comai G, Cappuccilli ML, Centofanti F, Carretta E, Plazzi G, Colì L, Montagna P, Stefoni S. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant. 2011 Jun; 26(6): 1976–83. Epub 2010 Nov 5. PMID: 21056943. DOI: 10.1093/ndt/gfq681
    Back to article
  30. 30Unruh ML, Levey AS, D’Ambrosio C, Fink NE, Powe NR, Meyer KB; Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis. 2004 May; 43(5): 900–9. PMID: 15112181. DOI: 10.1053/j.ajkd.2004.01.013
    Back to article
  31. 31Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996 Sep; 28(3): 372–8. PMID: 8804235. DOI: 10.1016/S0272-6386(96)90494-1
    Back to article
  32. 32DeFerio JJ, Govindarajulu U, Brar A, Cukor D, Lee KG, Salifu MO. Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS). BMC Nephrol. 2017 Aug 1; 18(1): 258. PMID: 28764654; PMCID: PMC5540277. DOI: 10.1186/s12882-017-0660-0
    Back to article
  33. 33Baiardi S, Mondini S, Baldi Antognini A, Santoro A, Cirignotta F. Survival of Dialysis Patients with Restless Legs Syndrome: A 15-Year Follow-Up Study. Am J Nephrol. 2017; 46(3): 224–230. Epub 2017 Sep 5. PMID: 28869939. DOI: 10.1159/000479938
    Back to article
  34. 34Losso RL, Minhoto GR, Riella MC. Sleep disorders in patients with end-stage renal disease undergoing dialysis: comparison between hemodialysis, continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Int Urol Nephrol. 2015 Feb; 47(2): 369–75. Epub 2014 Oct 31. PMID: 25358390. DOI: 10.1007/s11255-014-0860-5
    Back to article
  35. 35Al-Jahdali H. A comparison of sleep disturbances and sleep apnea in patients on hemodialysis and chronic peritoneal dialysis. Saudi J Kidney Dis Transpl. 2011 Sep; 22(5): 922–30. PMID: 21912020.
    Back to article
  36. 36Kashani E, Mirhosseini Z, Rastaghi S, Rad M. The Effect of the Cool Dialysate on the Restless Leg Syndrome in Hemodialysis Patients: Randomized Triple-Blind Clinical Trial. Iran J Nurs Midwifery Res. 2019 May–Jun; 24(3): 200–205. PMID: 31057636; PMCID: PMC6485020. DOI: 10.4103/ijnmr.IJNMR_133_18
    Back to article
  37. 37Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Giannaki CD, Mertens PR, Rountas C, Vlychou M, Liakopoulos V, Stefanidis I. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO J. 2008 Mar–Apr; 54(2): 185–90. PMID: 18356653. DOI: 10.1097/MAT.0b013e3181641b07
    Back to article
  38. 38Mortazavi M, Vahdatpour B, Ghasempour A, Taheri D, Shahidi S, Moeinzadeh F, Dolatkhah B, Dolatkhah S. Aerobic exercise improves signs of restless leg syndrome in end stage renal disease patients suffering chronic hemodialysis. Scientific World Journal. 2013 Nov 6; 2013: 628142. PMID: 24307876; PMCID: PMC3836425. DOI: 10.1155/2013/628142
    Back to article
  39. 39Mirbagher Ajorpaz N, Rahemi Z, Aghajani M, Hashemi SH. Effects of glycerin oil and lavender oil massages on hemodialysis patients’ restless legs syndrome. J Bodyw Mov Ther. 2020 Jan; 24(1): 88–92. Epub 2019 Jun 29. PMID: 31987569. DOI: 10.1016/j.jbmt.2019.06.012
    Back to article
  40. 40Oshvandi K, Mirzajani Letomi F, Soltanian AR, Shamsizadeh M. The effects of foot massage on hemodialysis patients’ sleep quality and restless leg syndrome: a comparison of lavender and sweet orange essential oil topical application. J Complement Integr Med. 2021 Apr 12; 18(4): 843–850. PMID: 33838094. DOI: 10.1515/jcim-2020-0121
    Back to article
  41. 41Amrollahi A, Rafiei A, Bahri A, Nasiriani K. Effects of aromatherapy massage on the severity of restless legs syndrome in hemodialysis patients: A randomized clinical trial. Ther Apher Dial. 2022 Jan 21; Epub ahead of print. PMID: 35060333. DOI: 10.1111/1744-9987.13802
    Back to article
  42. 42Döner A, Taşcı S. Effect of massage therapy with lavender oil on severity of restless legs syndrome and quality of life in hemodialysis patients. J Nurs Scholarsh. 2021 Nov 14; Epub ahead of print. PMID: 34779137. DOI: 10.1111/jnu.12738
    Back to article
  43. 43Hashemi SH, Hajbagheri A, Aghajani M. The effect of massage with lavender oil in restless legs syndrome in hemodialysis: a randomized controlled trial.
    Back to article
  44. 44Mortazavi M, Vahdatpour B, Ghasempour A, Taheri D, Shahidi S, Moeinzadeh F, Dolatkhah B, Dolatkhah S. Aerobic exercise improves signs of restless leg syndrome in end stage renal disease patients suffering chronic hemodialysis. Scientific World Journal. 2013 Nov 6; 2013: 628142. PMID: 24307876; PMCID: PMC3836425. DOI: 10.1155/2013/628142
    Back to article
  45. 45Trenkwalder C, Stiasny K, Pollmächer T, Wetter T, Schwarz J, Kohnen R, Kazenwadel J, Krüger HP, Ramm S, Künzel M, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep. 1995 Oct; 18(8): 681–8. PMID: 8560135. DOI: 10.1093/sleep/18.8.681
    Back to article
  46. 46Thorp ML, Morris CD, Bagby SP. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis. 2001 Jul; 38(1): 104–8. PMID: 11431189. DOI: 10.1053/ajkd.2001.25202
    Back to article
  47. 47Esteve V, Carneiro J, Salazar G, Pou M, Tapia I, Fulquet M, Duarte V, Saurina A, Moreno F, Ramírez de Arellano M. Effects of rotigotine on clinical symptoms, quality of life and sleep hygiene adequacy in haemodialysis-associated restless legs syndrome. Nefrologia (Engl Ed). 2018 Jan–Feb; 38(1): 79–86. English, Spanish. Epub 2017 Dec 2. PMID: 29198453. DOI: 10.1016/j.nefro.2017.03.023
    Back to article
  48. 48Cheikh Hassan HI, Brennan F, Collett G, Josland EA, Brown MA. Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients. Epub 2014 Sep 8. PMID: 25220049. DOI: 10.1016/j.jpainsymman.2014.08.010
    Back to article
  49. 49Dauvilliers Y, Benes H, Partinen M, Rauta V, Rifkin D, Dohin E, Goldammer N, Schollmayer E, Schröder H, Winkelman JW. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial. Am J Kidney Dis. 2016 Sep; 68(3): 434–43. Epub 2016 Feb 3. PMID: 26851201. DOI: 10.1053/j.ajkd.2015.12.027
    Back to article
  50. 50Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Kyriakides T, Koutedakis Y, Stefanidis I. Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol. 2013 Sep 11; 14: 194. PMID: 24024727; PMCID: PMC3847208. DOI: 10.1186/1471-2369-14-194
    Back to article
  51. 51Razazian N, Azimi H, Heidarnejadian J, Afshari D, Ghadami MR. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial. Saudi J Kidney Dis Transpl. 2015 Mar; 26(2): 271–8. PMID: 25758874. DOI: 10.4103/1319-2442.152417
    Back to article
  52. 52Ali M, Iram H, Nasim F, Solangi SA, Junejo AM, Un Nisa N, Solangi SA. Comparison of the Efficacy of Gabapentin Versus Levodopa-C for the Treatment of Restless Legs Syndrome in End-Stage Renal Disease on Hemodialysis Patients. Cureus. 2020 Dec 11; 12(12): e12034. PMID: 33457134; PMCID: PMC7797419. DOI: 10.7759/cureus.12034
    Back to article
  53. 53Micozkadioglu H, Ozdemir FN, Kut A, Sezer S, Saatci U, Haberal M. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study. Ren Fail. 2004 Jul; 26(4): 393–7. PMID: 15462107. DOI: 10.1081/JDI-120039823
    Back to article
  54. 54Pellecchia MT, Vitale C, Sabatini M, Longo K, Amboni M, Bonavita V, Barone P. Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release. Clin Neuropharmacol. 2004 Jul–Aug; 27(4): 178–81. PMID: 15319704. DOI: 10.1097/01.wnf.0000135480.78529.06
    Back to article
  55. 55Sagheb MM, Dormanesh B, Fallahzadeh MK, Akbari H, Sohrabi Nazari S, Heydari ST, Behzadi S. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Sleep Med. 2012 May; 13(5): 542–5. Epub 2012 Feb 7. PMID: 22317944. DOI: 10.1016/j.sleep.2011.11.010
    Back to article
  56. 56Dadashpour S, Hajmiri MS, Roshani D. Effect of intravenous vitamin C supplementation on the quality of sleep, itching and restless leg syndrome in patients undergoing hemodialysis; A double-blind randomized clinical trial. J. Nephropharmacol. 2018; 7: 131–136. DOI: 10.15171/npj.2018.27
    Back to article
  57. 57Rafie S, Jafari M. A comparative study on the effects of vitamin C and pramipexole on restless legs syndrome treatment in hemodialysis patients: A randomized, double blind, placebo-controlled trial. Int. J. Pharm. Res. Allied Sci. 2016; 5: 128–134
    Back to article
  58. 58Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004 Apr; 43(4): 663–70. PMID: 15042543. DOI: 10.1053/j.ajkd.2003.11.021
    Back to article
  59. 59Deng Y, Wu J, Jia Q. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. Med Sci Monit. 2017 Mar 12; 23: 1254–1260. PMID: 28285317; PMCID: PMC5360424. DOI: 10.12659/MSM.900520
    Back to article
  60. 60Earley CJ, Horská A, Mohamed MA, et al: A randomized, double-Blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med. 2009; 10: 206–11. DOI: 10.1016/j.sleep.2007.12.006
    Back to article
  61. 61Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S, Kavey N. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993 Jun; 16(4): 327–32. PMID: 8341893. DOI: 10.1093/sleep/16.4.327
    Back to article
  62. 62Trenkwalder C, Beneš H, Grote L, García-Borreguero D, Högl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R; RELOXYN Study Group. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013 Dec; 12(12): 1141–50. Epub 2013 Oct 18. Erratum in: Lancet Neurol. 2013 Dec; 12(12): 1133. PMID: 24140442. DOI: 10.1016/S1474-4422(13)70239-4
    Back to article
  63. 63de Biase S, Valente M, Gigli GL. Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxone. Neuropsychiatr Dis Treat. 2016 Feb 23; 12: 417–25. PMID: 26966363; PMCID: PMC4770072. DOI: 10.2147/NDT.S81186
    Back to article
  64. 64Riar SK, Leu RM, Turner-Green TC, Rye DB, Kendrick-Allwood SR, McCracken C, Bliwise DL, Greenbaum LA. Restless legs syndrome in children with chronic kidney disease. Pediatr Nephrol. 2013 May; 28(5): 773–95. Epub 2013 Jan 20. PMID: 23334386. DOI: 10.1007/s00467-013-2408-9
    Back to article
  65. 65Darwish AH, Abdel-Nabi H. Sleep disorders in children with chronic kidney disease. Int J Pediatr Adolesc Med. 2016 Sep; 3(3): 112–118. Epub 2016 Jun 29. PMID: 30805480; PMCID: PMC6372444. DOI: 10.1016/j.ijpam.2016.06.001
    Back to article
  66. 66Cheung V, Wertenteil S, Sasson S, Vento S, Kothare S, Trachtman H. Restless Legs Syndrome in Pediatric Patients With Nephrotic Syndrome. Glob Pediatr Health. 2015 May 11; 2: PMID: 27335958; PMCID: PMC4784599. DOI: 10.1177/2333794X15585994
    Back to article
  67. 67Davis ID, Greenbaum LA, Gipson D, Wu LL, Sinha R, Matsuda-Abedini M, Emancipator JL, Lane JC, Hodgkins K, Nailescu C, Barletta GM, Arora S, Mahan JD, Rosen CL. Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatr Nephrol. 2012 Mar; 27(3): 451–9. Epub 2011 Oct 2. PMID: 21964556. DOI: 10.1007/s00467-011-2010-y
    Back to article
  68. 68Applebee GA, Guillot AP, Schuman CC, Teddy S, Attarian HP. Restless legs syndrome in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2009 Mar; 24(3): 545–8. Epub 2008 Dec 2. PMID: 19048298. DOI: 10.1007/s00467-008-1057-x
    Back to article
  69. 69Sinha R, Davis ID, Matsuda-Abedini M. Sleep disturbances in children and adolescents with non-dialysis-dependent chronic kidney disease. Arch Pediatr Adolesc Med. 2009 Sep; 163(9): 850–5. PMID: 19736340. DOI: 10.1001/archpediatrics.2009.149
    Back to article
  70. 70Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, Zee PC, Gronseth GS, Gloss D, Zesiewicz T. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016 Dec 13; 87(24): 2585–2593. Epub 2016 Nov 16. PMID: 27856776; PMCID: PMC5206998. DOI: 10.1212/WNL.0000000000003388
    Back to article
  71. 71Gronseth G, French J. Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology. 2008 Nov 11; 71(20): 1639–43. PMID: 19001255. DOI: 10.1212/01.wnl.0000336535.27773.c0
    Back to article
  72. 72Handelman GJ. Vitamin C neglect in hemodialysis: sailing between Scylla and Charybdis. Blood Purif. 2007; 25(1): 58–61. Epub 2006 Dec 14. PMID: 17170539. DOI: 10.1159/000096399
    Back to article
  73. 73Tarng DC. Novel aspects of vitamin C in epoetin response. J Chin Med Assoc. 2007 Sep; 70(9): 357–60. PMID: 17908648. DOI: 10.1016/S1726-4901(08)70020-0
    Back to article
  74. 74Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, Winkelman JW, Trenkwalder C, Sampaio C. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§. Mov Disord. 2018 Jul; 33(7): 1077–1091. Epub 2018 May 14. PMID: 29756335. DOI: 10.1002/mds.27260
    Back to article
  75. 75Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain. 2020 May; 14(2): 104–114. Epub 2020 Mar 13. PMID: 32537149; PMCID: PMC7265598. DOI: 10.1177/2049463720912496
    Back to article
  76. 76Miranda M, Kagi M, Fabres L, Aguilera L, Alvo M, Elgueta L, Erazo S, Venegas P. Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis. Neurology. 2004 Mar 9; 62(5): 831–2. PMID: 15007148. DOI: 10.1212/01.WNL.0000113752.14744.15
    Back to article
  77. 77Collister D, Pohl K, Herrington G, Lee SF, Rabbat C, Tennankore K, Zimmermann D, Tangri N, Wald R, Manns B, Suri RS, Nadeau-Fredette AC, Goupil R, Silver SA, Walsh M. The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial. Can J Kidney Health Dis. 2020 Nov 26; 7: 2054358120968959. PMID: 33294203; PMCID: PMC7705292. DOI: 10.1177/2054358120968959
    Back to article
  78. 78Ma TT, Yang Z, Zhu S, Zhao JH, Li Y, Sun FY, Zhao N, Xiong ZY, Xiong ZB, Dong J. Pramipexole in peritoneal dialysis patients with restless legs syndrome (RLS): a protocol for a multicentre double-blind randomised controlled trial. BMJ Open. 2020 Feb 18; 10(2): e033815. PMID: 32075834; PMCID: PMC7045231. DOI: 10.1136/bmjopen-2019-033815
    Back to article
  79. 79Cawello W, Ahrweiler S, Sulowicz W, Szymczakiewicz-Multanowska A, Braun M. Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function. Br J Clin Pharmacol. 2012 Jan; 73(1): 46–54. PMID: 21707699; PMCID: PMC3248255. DOI: 10.1111/j.1365-2125.2011.04053.x
    Back to article
  80. 80Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004 Dec; 107(1): 1–16. PMID: 15567546. DOI: 10.1016/j.clineuro.2004.07.012
    Back to article
  81. 81Arnold R, Pussell BA, Kiernan MC, Krishnan AV. Comparative study to evaluate the effects of peritoneal and hemodialysis on peripheral nerve function. Muscle Nerve. 2016 Jun; 54(1): 58–64. Epub 2016 May 13. PMID: 26660121. DOI: 10.1002/mus.25016
    Back to article
  82. 82Ferdousi M, Azmi S, Kalteniece A, Khan SU, Petropoulos IN, Ponirakis G, Alam U, Asghar O, Marshall A, Soran H, Boulton AJM, Augustine T, Malik RA. No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease. J Peripher Nerv Syst. 2021 Sep; 26(3): 269–275. Epub 2021 Jun 10. PMID: 34085731. DOI: 10.1111/jns.12456
    Back to article
DOI: https://doi.org/10.5334/tohm.752 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jan 14, 2023
Accepted on: Mar 7, 2023
Published on: Mar 29, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Restless legs syndrome,
Movement disorders,
Renal failure,
Hemodialysis,
Sleep Disorders

© 2023 Yasaman Safarpour, Nosratola D. Vaziri, Bahman Jabbari, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 13 (2023): Issue 1Next article